QARZIBA 20.25 mg/4.5ml conc perf flac perf 1 pce
7680674630012
CH-67463
L01FX06
07.16.1.
Active substances:
1 / 3
google
Details
- Product number
- 6746301
- CPT
- -
- Packaging group
- 1
- Unit
- Flasche(n)
- Composition
- dinutuximabum beta 20.25 mg, saccharum, histidinum, polysorbatum 20, acidum hydrochloridum ad pH, aqua ad iniectabile q.s. ad solutionem pro 4.5 ml.
Articles (1)
Qarziba 20,25 mg/4,5 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
dinutuximabum beta
|
20.25 MG | Substance | Wirkstoff (Principe actif) |
|
saccharum
|
- | Substance | HNIDK |
|
histidinum
|
- | Substance | HNIDK |
|
polysorbatum 20
|
- | Substance | HNIDK |
|
acidum hydrochloridum
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 8602.80
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/03/2026
Authorization holder
Medius AG
4132 Muttenz
Authorization information
- Swissmedic authorization number
- 67463
- Drug name
- Qarziba, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L01FX06
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 18/04/2024
- Authorization expiration date
- 17/04/2029
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- QARZIBA 20.25 mg/4.5ml conc perf flac perf 1 pce
- Description (DE)
- QARZIBA 20.25 mg/4.5ml Konz Inf Durchstf 1 Stk
- Market launch
- 18/04/2024
- Narcotic (BTM)
- No